Takeover Rumors: Valeant Bids on Zoetis

Jun 26, 2015


Valeant Pharmaceuticals has approached animal-health giant Zoetis with a preliminary takeover bid, according to Bloomberg sources.

No information is available as to Zoetis' reaction to the proposed takover, but the company has long been discussed by analysts as a potential takeover target. Last year, after Valeant's takeover attempts of Allergan failed, many analysts speculated that acquiring Zoetis would be Valeant's backup plan.

Activist investor William Ackman -- who worked closely with Valeant CEO last year during Valeant’s failed takeover attempt of Allergan -- holds 8.4 percent of Zoetis shares. Shares of Zoetis rose 11 percent -- reaching the highest price the stock has been since it began trading in 2013.

Read the Bloomberg release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments